Global Cord Stem Cell Banking Market Reports, Industry Trends and Forecast, Outlook 2024 Insights


@databridgemarketresearch


The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –  Industry Trends and Forecast to 2024


The Global Cord Stem Cell Banking Market is expected to reach USD 9.44 billion by 2022 from USD 1.84 billion in 2016, at a CAGR of 22.4% in the forecast period 2017 to 2024. 



Cord Stem Cell Banking Market – Market Segmentation:


Based on product type the market is segmented into cord blood and cord blood & cord tissues. In 2016 the market is dominated by the cord blood segment with 63.7% market share in terms of value and is also expected to grow at the highest CAGR of 24.7% in the forecasted period 2016 to 2022.

On the basis of storage type the global cord stem cell banking market is segmented into public and private storage. In 2016, the public stem cell banks is expected to dominate the market in terms of market volume storage though the private banks is expected to dominate in terms of value. This is owing to the public stem cell banks not charging the customers for storage of stem cell but only charging for extraction which is done by third party agencies.


On the basis of service type the global cord stem cell banking market is segmented into collection & transportation, processing, analysis and storage. In 2016, the processing segment is expected to dominate the market with 47.3% market share and is expected to grow at a CAGR of 19.3% in the forecast period. The collection and transportation segment is expected to grow at the highest CAGR of 22.3% in the forecast period. However the services may vary very differently across countries owing to private banks charging very differently in different countries.


Based on Indication the market is segmented into cerebral palsy, thalassemia, autism, type 1 diabetes, anemia, leukemia, and others. Cerebral Palsy (CP) is most commonly described as the loss or impairment of motor skills. The research on treatment of CP with stem cells is in its preliminary stage, while the research on mesenchymal cells has shown a positive effect. Mesenchymal cells can’t develop into brain cells. However, they help to protect damaged cells and prolong their survival by releasing substances that help in the recovery of cells. Though there are 819.8 thousand samples stored still only approximately 8000 units were used. In 2016, cerebral palsy is expected to dominate the market with 24.7% market share.


On the basis of source the global cord stem cell banking market is segmented into umbilical cord blood, bone marrow, peripheral blood stem and menstrual blood. Among these, umbilical cord is the most preferred source, owing to the high multiplication capability of the umbilical cord stem cells and lesser rejection rate during transplantation. Furthermore, this method of extraction is noninvasive, and the stem cells are not affected by environment contamination.


There are already more than 550 stem cell banks present globally. With the increasing awareness about the potential of the stem cells in the treatment of diseases, the demand for stem cell storage for future use has increased significantly. Thus, several new companies have entered into the market in the recent years leading to high competition in the market. In order to gain competitive advantage companies are focusing on providing better quality and cost-efficient services, research, and marketing. Providing better services at lower cost will facilitate downward pricing strategy leading to loss of revenue to the market. The healthcare industry is already progressing at a highly competitive rate and this leads to fierce competition among the companies in this field leading to having an overall impact on the market size.



Based on geography, the market is segmented into five geographical regions:


·         North America

·         Europe

·         Asia-Pacific

·         South America

·         Middle East and Africa.


The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.


Some of the major players operating in this market are


1.       CBR Systems, Inc.

2.       Cordlife, CryoCell

3.       Cryo-Save AG

4.       Lifecell

5.       Stemcyte

6.       Viacord

7.       Smart Cells International, Ltd.

8.       Cryoviva India

9.       China Cord Blood Corporation



Table Of Content:


1.  INTRODUCTION

        1.1.      OVERVIEW OF THE CORD STEM CELL BANKING MARKET

        1.2.      MARKET SEGMENTATION & COVERAGE

                         1.2.1. CURRENCY AND PRICING

                         1.2.2. LIMITATION

2. RESEARCH METHODOLOGY

        2.1.      KEY TAKEAWAYS

        2.2.      ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE

                         2.2.1. MARKET CRACKDOWN APPROACH

                         2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                         2.2.3. DATA TRIANGULATION

                         2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                         2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                         2.2.6. PORTER’S FIVE FORCES MATRIX

                         2.2.7. PEST ANALYSIS

        2.4.      GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT

        2.3.      ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

        4.1.      OVERVIEW

        4.2.      CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS

        4.3.      MARKET OVERVIEW

                         4.3.1. DRIVERS

                               4.3.1.1.     EASY EXTRACTION METHODS

                               4.3.1.2.     RISING NUMBER OF NEWBORNS

                               4.3.1.3.     INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS

                               4.3.1.4.     NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT

                         4.3.2. RESTRAINTS

                               4.3.2.1.     LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES

                               4.3.2.2.     CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS

                               4.3.2.3.     HIGH OPERATING COST OF STEM CELL THERAPEUTICS

                        4.3.3. OPPORTUNITIES

                               4.3.2.1.     RISING AWARENESS ABOUT USAGE OF CORD TISSUE

                               4.3.2.2.     CORD BLOOD BANKS COLLABORATIONS

                               4.3.2.3.     INCREASED TECHNOLOGICAL DEVELOPMENT

                        4.3.4. THREATS

        4.4.      KEY MARKET FINDINGS

        4.5.      KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. CORD STEM CELL BANKING MARKET, BY STORAGE TYPE

        5.1.      OVERVIEW

        5.2.     PUBLIC CORD STEM CELL BANKING

                       5.2.1. MARKET VALUE, 2014 TO 2022

                       5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022

                       5.2.3. MARKET TRENDS AND FORECAST INSIGHTS

        5.3.      PRIVATE CORD STEM CELL BANKING

                       5.3.1. MARKET VALUE, 2014 TO 2022

                       5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022

                       5.3.3. MARKET TRENDS AND FORECAST INSIGHTS

        5.4.     COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING

6. CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE

        6.1.      OVERVIEW

        6.2.      CORD BLOOD

                       6.2.1. MARKET VALUE, 2014 TO 2022

                       6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022

                       6.2.3. MARKET TRENDS AND FORECAST INSIGHTS

        6.3.      CORD TISSUE AND CORD BLOOD

                       6.3.1. MARKET VALUE, 2014 TO 2022

                       6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022

                       6.3.3. MARKET TRENDS AND FORECAST INSIGHTS

7. CORD STEM CELL BANKING MARKET, BY SERVICE TYPE

        7.1.       OVERVIEW

        7.2.      COLLECTION & TRANSPORTATION

        7.3.      ANALYSIS

        7.4.      PROCESSING

        7.5.      STORAGE

8. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE

        8.1.      OVERVIEW

        8.2.      UMBILICAL CORD BLOOD

        8.3.      BONE MARROW

        8.4.     PERIPHERAL BLOOD STEM

        8.5.      MENSTRUAL BLOOD

9. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE

        9.1.      OVERVIEW

        9.2.      CEREBRAL PALSY

                       9.2.1. MARKET VALUE, 2014 TO 2022

                       9.2.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.2.3. MARKET TRENDS AND FORECAST INSIGHTS

        9.3.      THALASSEMIA

                       9.3.1. MARKET VALUE, 2014 TO 2022

                       9.3.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.3.3. MARKET TRENDS AND FORECAST INSIGHTS

        9.4.      LEUKEMIA

                       9.4.1. MARKET VALUE, 2014 TO 2022

                       9.4.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.4.3. MARKET TRENDS AND FORECAST INSIGHTS

        9.5.       DIABETES

                       9.5.1. MARKET VALUE, 2014 TO 2022

                       9.5.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.5.3. MARKET TRENDS AND FORECAST INSIGHTS

        9.6.      AUTISM

                       9.6.1. MARKET VALUE, 2014 TO 2022

                       9.6.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.6.3. MARKET TRENDS AND FORECAST INSIGHTS

        9.7.       OTHERS

                       9.7.1. MARKET VALUE, 2014 TO 2022

                       9.7.2. NUMBER OF UNITS USED, 2014 TO 2022

                       9.7.3. MARKET TRENDS AND FORECAST INSIGHTS

10. CORD STEM CELL BANKING MARKET, BY GEOGRAPHY

        10.1.     COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME)

                       10.1.1.      NORTH AMERICA

                                        10.1.1.1.      U.S.

                                        10.1.1.2.      CANADA

                                        10.1.1.3.      MEXICO

                       10.1.2.     EUROPE

                                        10.1.2.1.      GERMANY

                                        10.1.2.2.      FRANCE

                                        10.1.2.3.      U.K.

                                        10.1.2.4.      ITALY

                                        10.1.2.5.      SPAIN

                                        10.1.2.6.      RUSSIA

                                        10.1.2.7.      TURKEY

                                        10.1.2.8.      BELGIUM

                                        10.1.2.9.      NETHERLANDS

                                        10.1.2.10.      SWITZERLAND

                                        10.1.2.11.    REST OF EUROPE

                       10.1.3.      ASIA-PACIFIC (APAC)

                                        10.1.3.1.      JAPAN

                                        10.1.3.2.      CHINA

                                        10.1.3.3.      SOUTH KOREA

                                        10.1.3.4.      INDIA

                                        10.1.3.5.      AUSTRALIA

                                        10.1.3.6.      SINGAPORE

                                        10.1.3.7.      THAILAND

                                        10.1.3.8.      MALAYSIA

                                        10.1.3.9.      INDONESIA

                                        10.1.3.10.      PHILIPPINES

                                        10.1.3.11.      REST OF APAC

                       10.1.4.    LATIN AMERICA

                                        10.1.4.1.     BRAZIL

                                        10.1.4.2.     REST OF LATIN AMERICA

                       10.1.5.    MIDDLE EAST AND AFRICA

                                        10.1.5.1.     SOUTH AFRICA

                                        10.1.5.2.     REST OF MIDDLE EAST AND AFRICA

        10.2.     KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11. CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE

        11.1.     GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

        11.2.     NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

        11.3.     EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

        11.4.    APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

        11.5.    MERGERS & ACQUISITIONS

        11.6.    NEW PRODUCT DEVELOPMENT & APPROVALS

        11.7.     EXPANSIONS

        11.8.    REGULATORY CHANGES

        11.9.    PATENTS

        11.10.  PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12. CORD STEM CELL BANKING MARKET, COMPANY PROFILES

        12.1     CBR SYSTEMS, INC.

                     12.1.1   OVERVIEW

                     12.1.2   SWOT ANALYSIS

                     12.1.3   PRODUCT PORTFOLIO

                     12.1.4   REVENUE ANALYSIS

                     12.1.5   ANALYSTS VIEW

        12.2    CORDLIFE

                     12.2.1   OVERVIEW

                     12.2.2   SWOT ANALYSIS

                     12.2.3   PRODUCT PORTFOLIO

                     12.2.4   REVENUE ANALYSIS

                     12.2.5   ANALYSTS VIEW

        12.3    CRYOCELL

                     12.3.1   OVERVIEW

                     12.3.2   SWOT ANALYSIS

                     12.3.3   PRODUCT PORTFOLIO

                     12.3.4   REVENUE ANALYSIS

                     12.3.5   ANALYST VIEW

        12.4    CRYO-SAVE AG

                     12.4.1   OVERVIEW

                     12.4.2   SWOT ANALYSIS

                     12.4.3   PRODUCT PORTFOLIO

                     12.4.4   REVENUE ANALYSIS

                     12.4.5   ANALYSTS VIEW

        12.5    LIFECELL

                     12.5.1   OVERVIEW

                     12.5.2   SWOT ANALYSIS

                     12.5.3   PRODUCT PORTFOLIO

                     12.5.4   REVENUE ANALYSIS

                     12.5.5   ANALYSTS VIEW

        12.6    STEMCYTE

                     12.6.1   OVERVIEW

                     12.6.2   SWOT ANALYSIS

                     12.6.3   PRODUCT PORTFOLIO

                     12.6.4   REVENUE ANALYSIS

                     12.6.5   ANALYSTS VIEW

        12.7    SMART CELLS INTERNATIONAL, LTD.

                     12.7.1   OVERVIEW

                     12.7.2   SWOT ANALYSIS

                     12.7.3   PRODUCT PORTFOLIO

                     12.7.4   REVENUE ANALYSIS

                     12.7.5   ANALYSTS VIEW

        12.8   CRYOVIVA INDIA

                     12.8.1   OVERVIEW

                     12.8.2   SWOT ANALYSIS

                     12.8.3   PRODUCT PORTFOLIO

                     12.8.4   REVENUE ANALYSIS

                     12.8.5   ANALYSTS VIEW

        12.9   CHINA CORD BLOOD CORPORATION

                     12.9.1   OVERVIEW

                     12.9.2   SWOT ANALYSIS

                     12.9.3   PRODUCT PORTFOLIO

                     12.9.4   REVENUE ANALYSIS

                     12.9.5   ANALYSTS VIEW

        12.10 CRYOVIDA

                     12.10.1   OVERVIEW

                     12.10.2   SWOT ANALYSIS

                     12.10.3   PRODUCT PORTFOLIO

                     12.10.4   REVENUE ANALYSIS

                     12.10.5   ANALYSTS VIEW

        12.11  VIACORD

                     12.11.1   OVERVIEW

                     12.11.2   SWOT ANALYSIS

                     12.11.3   PRODUCT PORTFOLIO

                     12.11.4   REVENUE ANALYSIS

                     12.11.5   ANALYSTS VIEW

13. APPENDIX

        13.1    RELATED REPORTS

        13.2    CUSTOMIZABLE OPTIONS

        13.3    SOURCE SHEET

        13.3    BIBLIOGRAPHY

14. ABOUT DATA BRIDGE MARKET RESEARCH


Related Report


Global Hemostats Market- Trends and Forecast to 2024


Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024



About Data Bridge Market Research:


Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Contact:


Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Visit Blog http://databridgemarketresearch.com/blog/

Economy News